Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival
Epstein-Barr virus (EBV) is a prevalent oncogenic virus estimated to infect greater than 90% of the world’s population. Following initial infection, it establishes latency in host B cells. EBV has developed a multitude of techniques to avoid detection by the host immune system and establish lifelong...
Main Authors: | D. G. Sausen, M. C. Poirier, L. M. Spiers, E. N. Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1289313/full |
Similar Items
-
Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein–Barr Virus-Associated Malignancies
by: Xueyi Zheng, et al.
Published: (2022-05-01) -
Epstein-Barr virus: the mastermind of immune chaos
by: Jean de Melo Silva, et al.
Published: (2024-02-01) -
Epstein–Barr Virus: How Its Lytic Phase Contributes to Oncogenesis
by: Quincy Rosemarie, et al.
Published: (2020-11-01) -
Epstein-Barr Virus-Positive Lymphomas Exploit Ectonucleotidase Activity To Limit Immune Responses and Prevent Cell Death
by: Philip T. Lange, et al.
Published: (2023-04-01) -
Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies
by: Marcus Bauer, et al.
Published: (2021-10-01)